Dominant epitopes of cross‐reactive anti‐domain III human antibody response change from early to late convalescence of infection with dengue virus
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Luis Gabriel González-Lodeiro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biology, Biomedical Research, Center for Genetic Engineering and Biotechnology, Havana, Cuba. Hauptthemen laut MEDLINE: Dengue Virus, Dengue. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Cross‐neutralizing activity of human antibody response against Dengue virus complex (DENV) changes importantly over time. Domain III (DIII) of the envelope protein of DENV elicits a potently neutralizing and mostly type‐specific IgG response. We used sera from 24 individuals from early‐ or late convalescence of DENV1 infection to investigate the evolution of anti‐DIII human IgG with the time lapse since the infection. We evaluated the correlation between the serotype‐specific reactivity against recombinant DIII proteins and the neutralization capacity against the four serotypes, and examined its behavior with the time of convalescence. Also, we use a library of 71 alanine mutants of surface‐exposed amino acid residues to investigate the dominant epitopes. In early convalescence anti‐DIII titers and potency of virus neutralization were positively associated with correlation coefficients from 0.82 to 1.0 for the four serotypes. For late convalescence, a positive correlation ( r = 0.69) was found only for DENV1. The dominant epitope of the type‐specific response is centered in the FG‐loop (G383, E384, and K385) and includes most of the lateral ridge. The dominant epitope of the anti‐DIII cross‐reactive IgG in secondary infections shifts from the A‐strand during early convalescence to a site centered in residues E314‐H317 of the AB‐loop and I352‐E368 of the DI/DIII interface, in late convalescence. An immunoassay based on the detection of IgG anti‐DIII response can be implemented for detection of infecting serotype in diagnosis of DENV infection, either primary or secondary. Human dominant epitopes of the cross‐reactive circulating antibodies change with time of convalescence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Systems Biology, Biomedical Research, Center for Genetic Engineering and Biotechnology, Havana, Cuba.
- Faculty of Biology student, University of Havana, Havana, Cuba.
ORCID-Profile: Luis Gabriel González-Lodeiro, Alejandro Martín Dunn, Dayron Martín Prieto, Danya Medina-Carrasco, Vivian Huerta Galindo
Zitieren
APA
González-Lodeiro, L. G., Martín Dunn, A., Martín Prieto, D., Medina-Carrasco, D., García de Castro, L. E., Maldonado Bauzá, D., Chinea Santiago, G., & Huerta Galindo, V. (2024). Dominant epitopes of cross‐reactive anti‐domain III human antibody response change from early to late convalescence of infection with dengue virus. Journal of Medical Virology. https://doi.org/10.1002/jmv.29443
Vancouver
González-Lodeiro LG, Martín Dunn A, Martín Prieto D, Medina-Carrasco D, García de Castro LE, Maldonado Bauzá D, et al. Dominant epitopes of cross‐reactive anti‐domain III human antibody response change from early to late convalescence of infection with dengue virus. Journal of Medical Virology. 2024. doi:10.1002/jmv.29443
BibTeX
@article{GonzlezLodeiro2024,
author = {González-Lodeiro, Luis Gabriel and Martín Dunn, Alejandro and Martín Prieto, Dayron and Medina-Carrasco, Danya and García de Castro, Lisandra E and Maldonado Bauzá, Daniela and Chinea Santiago, Glay and Huerta Galindo, Vivian},
title = {Dominant epitopes of cross‐reactive anti‐domain III human antibody response change from early to late convalescence of infection with dengue virus},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29443}
}
EUVIMED